Clinical Study

The Effectiveness of Pre- and Postoperative Infliximab in Controlling Behçet’s Disease Posterior Uveitis in Patients Undergoing Vitrectomy: A Preliminary Study

Table 1

Demographic data and clinical presentations.

Demographic dataMean ± SDRange

Age (years)35.56 ± 5.1127–42
Duration (years)7.05 ± 2.223.5–10.5

Clinical presentationsN%

Ocular manifestations27100%
 Anterior uveitis518.5%
 Posterior uveitis27100%
 Vitreous cells & opacities27100%
 Retinal vasculitis518.5%
 Epiretinal membranes829.6%
 CME27.4%
Extraocular manifestations1555.6%

Number of patients.